BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 30279044)

  • 1. Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
    Qhobosheane MA; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Med Chem; 2018 Nov; 26(20):5531-5537. PubMed ID: 30279044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The monoamine oxidase inhibition properties of C6-mono- and N3/C6-disubstituted derivatives of 4(3H)-quinazolinone.
    Qhobosheane MA; Legoabe LJ; Petzer A; Petzer JP
    Bioorg Chem; 2019 Apr; 85():60-65. PubMed ID: 30599413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monoamine oxidase inhibition properties of C6- and N1-substituted 3-methyl-3,4-dihydroquinazolin-2(1H)-one derivatives.
    Marais L; Petzer A; Petzer JP; Legoabe LJ
    Mol Divers; 2020 May; 24(2):391-406. PubMed ID: 31115748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase.
    Engelbrecht I; Petzer JP; Petzer A
    Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
    Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
    Prins LH; Petzer JP; Malan SF
    Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
    Legoabe LJ; Petzer A; Petzer JP
    Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indanones as high-potency reversible inhibitors of monoamine oxidase.
    Mostert S; Petzer A; Petzer JP
    ChemMedChem; 2015 May; 10(5):862-73. PubMed ID: 25820651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
    Nel MS; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives.
    Meiring L; Petzer JP; Petzer A
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5498-502. PubMed ID: 24012182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Tetralone derivatives as inhibitors of monoamine oxidase.
    Legoabe LJ; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2758-63. PubMed ID: 24794105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C6- and C7-Substituted 3,4-dihydro-2(1H)-quinolinones as Inhibitors of Monoamine Oxidase.
    Meiring L; Petzer JP; Petzer A
    Drug Res (Stuttg); 2017 Mar; 67(3):170-178. PubMed ID: 27926950
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents.
    Agrawal N; Mishra P
    Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of monoamine oxidase by phthalide analogues.
    Strydom B; Bergh JJ; Petzer JP
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1269-73. PubMed ID: 23374869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    Gökhan-Kelekçi N; Koyunoğlu S; Yabanoğlu S; Yelekçi K; Ozgen O; Uçar G; Erol K; Kendi E; Yeşilada A
    Bioorg Med Chem; 2009 Jan; 17(2):675-89. PubMed ID: 19091581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase inhibitory activities of heterocyclic chalcones.
    Minders C; Petzer JP; Petzer A; Lourens AC
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5270-6. PubMed ID: 26432037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Evaluation of 2-benzylidene-1-tetralone Derivatives for Monoamine Oxidase Inhibitory Activity.
    Amakali KT; Legoabe LJ; Petzer A; Petzer JP
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):136-149. PubMed ID: 29714148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson's disease therapy.
    Yeon SK; Choi JW; Park JH; Lee YR; Kim HJ; Shin SJ; Jang BK; Kim S; Bahn YS; Han G; Lee YS; Pae AN; Park KD
    Bioorg Med Chem; 2018 Jan; 26(1):232-244. PubMed ID: 29198609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of pyrrolo[3,4-f]indole-5,7-dione and indole-5,6-dicarbonitrile derivatives as inhibitors of monoamine oxidase.
    Chirkova ZV; Kabanova MV; Filimonov SI; Abramov IG; Petzer A; Hitge R; Petzer JP; Suponitsky KY
    Drug Dev Res; 2019 Nov; 80(7):970-980. PubMed ID: 31348537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.